EDWARD PENHOET
CIK 1198332 · last filed 2019-04-04
EDWARD PENHOET is a corporate insider who has filed 33 SEC Form 4 insider transactions across 7 companies since 2007. Across all open-market trades the lifetime net is +$482.5K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $452.9M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$452.88M
7
33
$482.5K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCYX | Director | — | $3.80 | — | $0 | 1 | 2015-06-05 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 1 | 2015-01-08 |
| CCXI | Director | 114,910 | $10.32 | $1.19M | $0 | 3 | 2013-05-24 |
| ZYMOGENETICS INC (ZGEN) Delisted | Director | 0 | $12.01 | $0 | $0 | 6 | 2010-10-12 |
| CORT | Director | 5,525,313 | $81.75 | $451.69M | $482.5K | 5 | 2010-04-06 |
| IDM PHARMA, INC. (IDMI) Delisted | Director | 1,829 | — | — | $0 | 4 | 2008-06-26 |
| RENOVIS INC (RNVS) Delisted | Director | 79,028 | — | — | $0 | 2 | 2007-05-16 |
Recent Filings
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-04-04 | — | Disp (D) | — | $0 | |
| 2019-01-07 | — | Grant (A) | — | $0 | |
| 2018-01-08 | — | Grant (A) | — | $0 | |
| 2017-01-06 | — | Grant (A) | — | $0 | |
| 2016-01-06 | — | Grant (A) | — | $0 | |
| 2015-06-05 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2015-01-09 | — | Grant (A) | — | $0 | |
| 2015-01-08 | CymaBay Therapeutics, Inc. (CBAY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2014-07-31 | — | Mixed | +2,482,775 | $3.59M | |
| 2014-01-15 | — | Grant (A) | — | $0 |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.